Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Scopus BioPharma Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +7 vs. Q3 2021
- Shares held
- 2.88M
- +2.61M (+947.5%) vs. Q3 2021
- Total value
- $4.71M
- +$3.57M (+313.3%) vs. Q3 2021
- New holders
- 8
- 5 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 1 | $7.49K |
| Q3 2022 | 15 | $110.6K |
| Q2 2022 | 17 | $293.0K |
| Q1 2022 | 19 | $693.0K |
| Q4 2021 | 21 | $4.71M |
| Q3 2021 | 14 | $1.14M |
| Q2 2021 | 15 | $1.07M |
| Q1 2021 | 28 | $4.89M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Scopus BioPharma Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 2,100,000 | $3.43M | 0.08% | +2,100,000 | New |
| Vanguard Group Inc | 363,041 | $594.0K | 0.00% | +363,041 | New |
| Bridgeway Capital Management, LLC | 93,966 | $154.0K | 0.00% | +23,100+32.6% | Added |
| Geode Capital Management, LLC | 66,121 | $108.0K | 0.00% | +66,121 | New |
| Morgan Stanley | 44,012 | $72.0K | 0.00% | +43,012+4,301.2% | Added |
| Two Sigma Investments, LP | 30,403 | $50.0K | 0.00% | +30,403 | New |
| Millennium Management LLC | 27,043 | $44.0K | 0.00% | −74,611−73.4% | Reduced |
| First Manhattan Co | 25,800 | $42.0K | 0.00% | −2,000−7.2% | Reduced |
| Renaissance Technologies LLC | 20,900 | $34.0K | 0.00% | +20,900 | New |
| Citadel Advisors LLC | 20,897 | $34.0K | 0.00% | +20,897 | New |
| State Street Corp | 19,900 | $33.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 19,528 | $32.0K | 0.00% | +510+2.7% | Added |
| Virtu Financial LLC | 15,031 | $25.0K | 0.00% | +15,031 | New |
| Northern Trust Corp | 12,516 | $20.0K | 0.00% | +12,516 | New |
| Tower Research Capital LLC (TRC) | 5,737 | $9.00K | 0.00% | −16,981−74.7% | Reduced |
| JPMorgan Chase & Co | 5,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,840 | $8.00K | 0.00% | +4,740+4,740.0% | Added |
| Compagnie Lombard Odier SCmA | 4,360 | $7.00K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 1,000 | $2.00K | 0.00% | −475−32.2% | Reduced |
| Royal Bank of Canada | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 63 | $0 | 0.00% | +14+28.6% | Added |
| FMR LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |